364 related articles for article (PubMed ID: 31434359)
21. Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer.
Liu S; Cao Q; An G; Yan B; Lei L
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302562
[TBL] [Abstract][Full Text] [Related]
22. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
[TBL] [Abstract][Full Text] [Related]
23. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.
Arndt GM; Dossey L; Cullen LM; Lai A; Druker R; Eisbacher M; Zhang C; Tran N; Fan H; Retzlaff K; Bittner A; Raponi M
BMC Cancer; 2009 Oct; 9():374. PubMed ID: 19843336
[TBL] [Abstract][Full Text] [Related]
24. A Systems Biology Approach to Identify Novel Biomarkers in Progression from Crohn's Disease to Colorectal Cancer.
Shokrollah N; Samadi P; Jalali A; Dalirfardouei R; Afshar S; Pourjafar M
Asian Pac J Cancer Prev; 2023 Jun; 24(6):1993-2001. PubMed ID: 37378929
[TBL] [Abstract][Full Text] [Related]
25. Identification of Differentially Expressed MicroRNAs involved in the Pathogenesis of Colorectal Cancer.
Feng H; Xu M; Zhang Y; Han B; Wang J; Sun P
Clin Lab; 2018 May; 64(5):797-804. PubMed ID: 29739047
[TBL] [Abstract][Full Text] [Related]
26. Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.
Bullock MD; Pickard K; Mitter R; Sayan AE; Primrose JN; Ivan C; Calin GA; Thomas GJ; Packham GK; Mirnezami AH
Oncotarget; 2015 Mar; 6(9):7262-79. PubMed ID: 25788261
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
28. The TGFβ-signaling pathway and colorectal cancer: associations between dysregulated genes and miRNAs.
Pellatt AJ; Mullany LE; Herrick JS; Sakoda LC; Wolff RK; Samowitz WS; Slattery ML
J Transl Med; 2018 Jul; 16(1):191. PubMed ID: 29986714
[TBL] [Abstract][Full Text] [Related]
29. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
[TBL] [Abstract][Full Text] [Related]
30. Whole-transcriptome analysis reveals a potential hsa_circ_0001955/hsa_circ_0000977-mediated miRNA-mRNA regulatory sub-network in colorectal cancer.
Ding B; Yao M; Fan W; Lou W
Aging (Albany NY); 2020 Mar; 12(6):5259-5279. PubMed ID: 32221048
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
[TBL] [Abstract][Full Text] [Related]
32. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
[TBL] [Abstract][Full Text] [Related]
33. Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment.
Ragusa M; Majorana A; Statello L; Maugeri M; Salito L; Barbagallo D; Guglielmino MR; Duro LR; Angelica R; Caltabiano R; Biondi A; Di Vita M; Privitera G; Scalia M; Cappellani A; Vasquez E; Lanzafame S; Basile F; Di Pietro C; Purrello M
Mol Cancer Ther; 2010 Dec; 9(12):3396-409. PubMed ID: 20881268
[TBL] [Abstract][Full Text] [Related]
34. MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.
Chen E; Li Q; Wang H; Yang F; Min L; Yang J
Biomed Pharmacother; 2018 Oct; 106():1370-1377. PubMed ID: 30119209
[TBL] [Abstract][Full Text] [Related]
35. An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer.
Samadi P; Soleimani M; Nouri F; Rahbarizadeh F; Najafi R; Jalali A
BMC Cancer; 2022 Jul; 22(1):835. PubMed ID: 35907803
[TBL] [Abstract][Full Text] [Related]
36. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
37. Identification of Diagnostic Exosomal LncRNA-miRNA-mRNA Biomarkers in Colorectal Cancer Based on the ceRNA Network.
Zhao Y; Song X; Song X; Xie L
Pathol Oncol Res; 2022; 28():1610493. PubMed ID: 36185995
[No Abstract] [Full Text] [Related]
38. Identification of an MiRNA-mRNA Regulatory Network in Colorectal Cancer.
Cui MF; Wu YY; Chen MY; Zhao Y; Han SY; Wang RJ; Zhang H; Fang XD
Comb Chem High Throughput Screen; 2021; 24(10):1736-1745. PubMed ID: 33172374
[TBL] [Abstract][Full Text] [Related]
39. Identifying miRNA/mRNA negative regulation pairs in colorectal cancer.
Zhou X; Xu X; Wang J; Lin J; Chen W
Sci Rep; 2015 Aug; 5():12995. PubMed ID: 26269151
[TBL] [Abstract][Full Text] [Related]
40. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
